AINOVO Trademark

Trademark Overview

On Wednesday, January 20, 2021, a trademark application was filed for AINOVO with the United States Patent and Trademark Office. The USPTO has given the AINOVO trademark a serial number of 90477595. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, May 24, 2024. This trademark is owned by AINovo Biotech Inc.. The AINOVO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Mixed biological preparations for the prevention...
ainovo

General Information

Serial Number90477595
Word MarkAINOVO
Filing DateWednesday, January 20, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, May 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 19, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Mixed biological preparations for the prevention and treatment of infectious diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 21, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAINovo Biotech Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGilbert, AZ 85233
Party NameAINovo Biotech Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGilbert, AZ 85233

Trademark Events

Event DateEvent Description
Saturday, January 23, 2021NEW APPLICATION ENTERED
Wednesday, April 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 3, 2021ASSIGNED TO EXAMINER
Monday, August 9, 2021NON-FINAL ACTION WRITTEN
Monday, August 9, 2021NON-FINAL ACTION E-MAILED
Monday, August 9, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 9, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, February 13, 2022ASSIGNED TO LIE
Monday, February 14, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 14, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 16, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 16, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, March 16, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 16, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, March 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 19, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 14, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 30, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 30, 2022SOU EXTENSION 1 FILED
Wednesday, November 30, 2022SOU EXTENSION 1 GRANTED
Friday, December 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 13, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 13, 2023TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, June 13, 2023DIVISIONAL REQUEST RECEIVED
Tuesday, June 13, 2023SOU EXTENSION 2 FILED
Tuesday, June 13, 2023TEAS REQUEST TO DIVIDE RECEIVED
Monday, July 3, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 10, 2023ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Wednesday, August 9, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 9, 2023RESPONSE TO ITU OFFICE ACTION ENTERED
Wednesday, August 9, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 11, 2023REVIEW OF CORRESPONDENCE COMPLETE
Friday, August 11, 2023DIVISIONAL PROCESSING COMPLETE
Friday, August 11, 2023SOU EXTENSION 2 GRANTED
Saturday, August 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 27, 2023SOU EXTENSION 3 FILED
Monday, November 27, 2023SOU EXTENSION 3 GRANTED
Friday, May 24, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 24, 2024SOU EXTENSION 4 FILED
Friday, May 24, 2024SOU EXTENSION 4 GRANTED
Tuesday, August 22, 2023CORRECTED NOA E-MAILED
Monday, November 27, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

ainovo preparations treatment pharmaceutical diseases prevention cancer delivery products disorders viral